DelveInsight's Interferons Market Insights report provides the current and forecast market analysis, individual leading ...

There is a fascinating field of study called Psychoneuroimmunology (PNI), which investigates the connections between the ...

There is a fascinating field of study called Psychoneuroimmunology (PNI), which investigates the connections between the ...

The essential thrombocythemia market is expected to grow steadily due to increasing disease prevalence, advancements in targeted therapies, and risin ...

The Interferon (IFN) Induced Helicase C domain 1 gene IFIH1 gene encodes the Melanoma Differentiation–Associated protein 5 (MDA5), which belongs to the RIG-I-Like Receptors (RLRs) family, a group of ...

The risk of disease activity in going to a less effective DMT was higher in younger adults and those having prior ...

The increasing occurrence of chronic and infectious diseases is the main driver of the rising demand for interferon. Furthermore, advancements in interferon production and ongoing research and ...

Feb. 19, 2025 — Breast cancer incidence trends in U.S. women under 40 vary by geography and supports incorporating location information with established risk factors into risk prediction ...

June 20, 2024 — Research scientists found that a 'one-two punch' of combining the immunosuppressive drug ruxolitinib with existing checkpoint inhibitor therapies may be a more effective way to ...

Voyager Therapeutics’ progress with drug candidates targeting tau marks a step in how the industry is walking multiple paths toward new therapeutic options.

Reported positive six-month data from ADVANCED-2 trial of TARA-002 in patients with NMIBC; Announcement of initial data from 12-month evaluable ...

在我国现有口服高效DMT中，奥扎莫德是拥有新分子结构的全新一代S1PR调节剂，选择性作用于S1PR1和S1PR5。奥扎莫德的表观分布容积高达5590L，具有更强的血脑屏障穿透能力，其在脑组织中的浓度与血药浓度比值高达 (10~16) : ...